336 related articles for article (PubMed ID: 25126543)
1. Ligation strategies for targeting liposomal nanocarriers.
Marqués-Gallego P; de Kroon AI
Biomed Res Int; 2014; 2014():129458. PubMed ID: 25126543
[TBL] [Abstract][Full Text] [Related]
2. Liposomal drug delivery systems: from concept to clinical applications.
Allen TM; Cullis PR
Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
[TBL] [Abstract][Full Text] [Related]
3. Recent Progress in Bioconjugation Strategies for Liposome-Mediated Drug Delivery.
Almeida B; Nag OK; Rogers KE; Delehanty JB
Molecules; 2020 Dec; 25(23):. PubMed ID: 33271886
[TBL] [Abstract][Full Text] [Related]
4. Future directions of liposome- and immunoliposome-based cancer therapeutics.
Park JW; Benz CC; Martin FJ
Semin Oncol; 2004 Dec; 31(6 Suppl 13):196-205. PubMed ID: 15717745
[TBL] [Abstract][Full Text] [Related]
5. Design of liposomal formulations for cell targeting.
Nogueira E; Gomes AC; Preto A; Cavaco-Paulo A
Colloids Surf B Biointerfaces; 2015 Dec; 136():514-26. PubMed ID: 26454541
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape.
Zylberberg C; Matosevic S
Drug Deliv; 2016 Nov; 23(9):3319-3329. PubMed ID: 27145899
[TBL] [Abstract][Full Text] [Related]
7. Liposomal doxorubicin as targeted delivery platform: Current trends in surface functionalization.
Makwana V; Karanjia J; Haselhorst T; Anoopkumar-Dukie S; Rudrawar S
Int J Pharm; 2021 Jan; 593():120117. PubMed ID: 33259901
[TBL] [Abstract][Full Text] [Related]
8. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
[TBL] [Abstract][Full Text] [Related]
9. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential.
Immordino ML; Dosio F; Cattel L
Int J Nanomedicine; 2006; 1(3):297-315. PubMed ID: 17717971
[TBL] [Abstract][Full Text] [Related]
10. Liposomal nanostructures for photosensitizer delivery.
Jin CS; Zheng G
Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in liposome formulations for breast cancer therapeutics.
Yang B; Song BP; Shankar S; Guller A; Deng W
Cell Mol Life Sci; 2021 Jul; 78(13):5225-5243. PubMed ID: 33974093
[TBL] [Abstract][Full Text] [Related]
12. Liposome-based diagnostic and therapeutic applications for pancreatic cancer.
Raza F; Evans L; Motallebi M; Zafar H; Pereira-Silva M; Saleem K; Peixoto D; Rahdar A; Sharifi E; Veiga F; Hoskins C; Paiva-Santos AC
Acta Biomater; 2023 Feb; 157():1-23. PubMed ID: 36521673
[TBL] [Abstract][Full Text] [Related]
13. Ligand-targeted liposome design: challenges and fundamental considerations.
Noble GT; Stefanick JF; Ashley JD; Kiziltepe T; Bilgicer B
Trends Biotechnol; 2014 Jan; 32(1):32-45. PubMed ID: 24210498
[TBL] [Abstract][Full Text] [Related]
14. Challenges in development of targeted liposomal therapeutics.
Sawant RR; Torchilin VP
AAPS J; 2012 Jun; 14(2):303-15. PubMed ID: 22415612
[TBL] [Abstract][Full Text] [Related]
15. Sticking the Landing: Enhancing Liposomal Cell Delivery using Reversible Covalent Chemistry and Caged Targeting Groups.
Lou J; Qualls ML; Best MD
Chembiochem; 2023 Jan; 24(2):e202200436. PubMed ID: 36164720
[TBL] [Abstract][Full Text] [Related]
16. Lipid-Based Antimicrobial Delivery-Systems for the Treatment of Bacterial Infections.
Wang DY; van der Mei HC; Ren Y; Busscher HJ; Shi L
Front Chem; 2019; 7():872. PubMed ID: 31998680
[TBL] [Abstract][Full Text] [Related]
17. Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential.
Gregoriadis G; Florence AT
Drugs; 1993 Jan; 45(1):15-28. PubMed ID: 7680982
[TBL] [Abstract][Full Text] [Related]
18. Molecular targeting of liposomal nanoparticles to tumor microenvironment.
Zhao G; Rodriguez BL
Int J Nanomedicine; 2013; 8():61-71. PubMed ID: 23293520
[TBL] [Abstract][Full Text] [Related]
19. Challenges and pitfalls in the development of liposomal delivery systems for cancer therapy.
Moosavian SA; Bianconi V; Pirro M; Sahebkar A
Semin Cancer Biol; 2021 Feb; 69():337-348. PubMed ID: 31585213
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-reduced gold nanoparticles: a novel carrier for the preparation of spray-dried liposomes for topical delivery.
Padamwar MN; Patole MS; Pokharkar VB
J Liposome Res; 2011 Dec; 21(4):324-32. PubMed ID: 21623705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
